Cargando…

Additive Therapy of Plasmodium berghei-Induced Experimental Cerebral Malaria via Dihydroartemisinin Combined with Rapamycin and Atorvastatin

Cerebral malaria (CM), caused by Plasmodium falciparum, is the primary cause of death from severe malaria. Even after immediate parenteral therapy with antimalarial drugs, the mortality rate remains 15 to 25%. Currently, no effective therapeutic agents are available for the radical treatment of CM....

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Xiaonan, Cheng, Weijia, Zhu, Huiyin, Li, Yuting, Li, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101104/ https://www.ncbi.nlm.nih.gov/pubmed/36946739 http://dx.doi.org/10.1128/spectrum.02317-22

Ejemplares similares

Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model
por: Dormoi, Jérôme, et al.
Publicado: (2013)

Cerebral malaria induced by plasmodium falciparum: clinical features, pathogenesis, diagnosis, and treatment
por: Song, Xiaonan, et al.
Publicado: (2022)

Efficacy of Different Nitric Oxide-Based Strategies in Preventing Experimental Cerebral Malaria by Plasmodium berghei ANKA
por: Martins, Yuri C., et al.
Publicado: (2012)

Synergistic antimalarial treatment of Plasmodium berghei infection in mice with dihydroartemisinin and Gymnema inodorum leaf extract
por: Ounjaijean, Sakaewan, et al.
Publicado: (2023)

Plasmodium berghei ANKA Infection in ICR Mice as a Model of Cerebral Malaria
por: Basir, R, et al.
Publicado: (2012)

Young Sprague Dawley rats infected by Plasmodium berghei: A relevant experimental model to study cerebral malaria
por: Keita Alassane, Sokhna, et al.
Publicado: (2017)

Antimalarial Efficacy of Aqueous Extract of Strychnos ligustrina and Its Combination with Dihydroartemisinin and Piperaquine Phosphate (DHP) against Plasmodium berghei Infection
por: Cahyaningsih, Umi, et al.
Publicado: (2022)

Characterization of Plasmodium berghei Homologues of T-cell Immunomodulatory Protein as a New Potential Candidate for Protecting against Experimental Cerebral Malaria
por: Cui, Ai, et al.
Publicado: (2019)

Dihydroartemisinin‐piperaquine for treating uncomplicated Plasmodium falciparum malaria
por: Zani, Babalwa, et al.
Publicado: (2014)

Protection from Experimental Cerebral Malaria with a Single Dose of Radiation-Attenuated, Blood-Stage Plasmodium berghei Parasites
por: Gerald, Noel J., et al.
Publicado: (2011)

In vitro culture of Plasmodium berghei-ANKA maintains infectivity of mouse erythrocytes inducing cerebral malaria
por: Jambou, Ronan, et al.
Publicado: (2011)

Euterpe oleracea fruit (Açai)-enriched diet suppresses the development of experimental cerebral malaria induced by Plasmodium berghei (ANKA) infection
por: Oliveira, Karen Renata Herculano Matos, et al.
Publicado: (2022)

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
por: Phuc, Bui Quang, et al.
Publicado: (2017)

Pathogenesis of Plasmodium berghei ANKA infection in the gerbil (Meriones unguiculatus) as an experimental model for severe malaria
por: Junaid, Quazim Olawale, et al.
Publicado: (2017)

Effect of Allicin and Artesunate Combination Treatment on Experimental Mice Infected with Plasmodium berghei
por: Ounjaijean, Sakaewan, et al.
Publicado: (2022)

Enantiomerically pure amino-alcohol quinolines: in vitro anti-malarial activity in combination with dihydroartemisinin, cytotoxicity and in vivo efficacy in a Plasmodium berghei mouse model
por: Mullié, Catherine, et al.
Publicado: (2014)

Phagotrophy and Two New Structures in the Malaria Parasite Plasmodium berghei
por: Rudzinska, Maria A., et al.
Publicado: (1959)

Plasmodium berghei ANKA causes intestinal malaria associated with dysbiosis
por: Taniguchi, Tomoyo, et al.
Publicado: (2015)

Nuclear Pore Complex Components in the Malaria Parasite Plasmodium berghei
por: Kehrer, Jessica, et al.
Publicado: (2018)

Plasmodium berghei-induced malaria decreases pain sensitivity in mice
por: Oyewole, Aboyeji L., et al.
Publicado: (2021)

Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model
por: Souraud, Jean-Baptiste, et al.
Publicado: (2012)

Eosinophils Suppress the Migration of T Cells Into the Brain of Plasmodium berghei-Infected Ifnar1(-/-) Mice and Protect Them From Experimental Cerebral Malaria
por: Scheunemann, Johanna F., et al.
Publicado: (2021)

Detection of Antimalarial Resistance-Associated Mutations in Plasmodium falciparum via a Platform of Allele-Specific PCR Combined with a Gold Nanoparticle-Based Lateral Flow Assay
por: Cheng, Weijia, et al.
Publicado: (2022)

Observation of the Gut Microbiota Profile in C57BL/6 Mice Induced by Plasmodium berghei ANKA Infection
por: Guan, Wei, et al.
Publicado: (2021)

Testing the impact of a single nucleotide polymorphism in a Plasmodium berghei ApiAP2 transcription factor on experimental cerebral malaria in mice
por: Akkaya, Munir, et al.
Publicado: (2020)

G6pd-Deficient Mice Are Protected From Experimental Cerebral Malaria and Liver Injury by Suppressing Proinflammatory Response in the Early Stage of Plasmodium berghei Infection
por: Yi, Haoan, et al.
Publicado: (2021)

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
por: Mueller, Ann-Kristin, et al.
Publicado: (2014)

Parasite densities modulate susceptibility of mice to cerebral malaria during co-infection with Schistosoma japonicum and Plasmodium berghei
por: Wang, Mei-lian, et al.
Publicado: (2014)

Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice
por: Recuenco, Frances C, et al.
Publicado: (2014)

Attenuated T Cell Responses Are Associated With the Blockade of Cerebral Malaria Development by YOP1-Deficient Plasmodium berghei ANKA
por: Hai, Lei, et al.
Publicado: (2021)

Corrigendum: Plasmodium berghei ANKA causes intestinal malaria associated with dysbiosis
por: Taniguchi, Tomoyo, et al.
Publicado: (2016)

Antiplasmodial Effect of Anthocleista vogelii on Albino Mice Experimentally Infected with Plasmodium berghei berghei (NK 65)
por: Gboeloh, Lebari Barine, et al.
Publicado: (2014)

Inhibiting the Mammalian Target of Rapamycin Blocks the Development of Experimental Cerebral Malaria
por: Gordon, Emile B., et al.
Publicado: (2015)

Melatonin Prevents Brain Damage and Neurocognitive Impairment Induced by Plasmodium Berghei ANKA Infection in Murine Model of Cerebral Malaria
por: Ataide, Brenda Jaqueline de Azevedo, et al.
Publicado: (2020)

Evaluation of immunity against malaria using luciferase-expressing Plasmodium berghei parasites
por: Ploemen, Ivo, et al.
Publicado: (2011)

Visualization of Malaria Parasites in the Skin Using the Luciferase Transgenic Parasite, Plasmodium berghei
por: Matsuoka, Hiroyuki, et al.
Publicado: (2015)

A Plasmodium berghei sporozoite-based vaccination platform against human malaria
por: Mendes, António M., et al.
Publicado: (2018)

Upper gastrointestinal pathophysiology due to mouse malaria Plasmodium berghei ANKA infection
por: Shimada, Mizuho, et al.
Publicado: (2019)

Trichinella spiralis co-infection exacerbates Plasmodium berghei malaria-induced hepatopathy
por: Mei, Xu, et al.
Publicado: (2020)

Distinct placental malaria pathology caused by different Plasmodium berghei lines that fail to induce cerebral malaria in the C57BL/6 mouse
por: Rodrigues-Duarte, Lurdes, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rrp367vj94j48bggg0njkacbe2